Prelizer Launch
10 July, 2024

Radiant Pharmaceuticals Launches Prelizer-AM™ Bisoprolol Fumarate & Amlodipine Besylate

Share

On September 20, 2023, as a line extension of Bisoprolol brand Prelizer, Prelizer AM 2.5/5 mg Tablets (Bisoprolol Fumarate & Amlodipine Besylate) and Prelizer HTZ 2.5/6.25 mg & 5/6 .25 mg tablet (Bisoprolol Fumarate BP & Hydrochlorothiazide USP) has begun to be marketed by Radiant Pharmaceuticals Limited.

Prilizar AM is highly effective in controlling uncontrolled high blood pressure. And Prilizar HTZ is highly effective in controlling edema and hypertension.

Prelizer-HTZ 2.5/6.25 (Bisoprolol Fumarate BP & Hydrochlorothiazide USP)

Prelizer 5

Prelizer-AM 2.5/5

Prelizer 2.5

Share
Prelizer Launch
Table of Contents

On September 20, 2023, as a line extension of Bisoprolol brand Prelizer, Prelizer AM 2.5/5 mg Tablets (Bisoprolol Fumarate & Amlodipine Besylate) and Prelizer HTZ 2.5/6.25 mg & 5/6 .25 mg tablet (Bisoprolol Fumarate BP & Hydrochlorothiazide USP) has begun to be marketed by Radiant Pharmaceuticals Limited.

Prilizar AM is highly effective in controlling uncontrolled high blood pressure. And Prilizar HTZ is highly effective in controlling edema and hypertension.

Prelizer-HTZ 2.5/6.25 (Bisoprolol Fumarate BP & Hydrochlorothiazide USP)

Prelizer 5

Prelizer-AM 2.5/5

Prelizer 2.5

Table of Contents

Confidentiality Note:

Any information related to the identities of the patient and reporter will be kept confidential unless it is subject to disclose due to regulatory obligation.

AcceptDecline